Celadon Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Celadon Pharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 213% to $75,000. The net income raised on -$7,140,000 and profit margin reached -9520%. Total operating expenses were $5,757,000.
Profit Margin
| 2019 | 0 | -191.32K | |
|---|---|---|---|
| 2020 | 0 | -1.39M | |
| 2021 | 2K | -4.78M | -239150% |
| 2022 | 24K | -17.41M | -72545.83% |
| 2023 | 75K | -7.14M | -9520% |
CEL.L Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 75K | 24K | 2K | 0 | 0 |
Cost of revenue | 0 | 90K | 12K | 0 | 0 |
Gross profit | 75K | -66K | -10K | 0 | 0 |
Operating exp. | |||||
Research and development | 0 | 0 | 0 | 217.10K | 0 |
Selling and marketing | 0 | 0 | 0 | 0 | 119.09K |
Total operating expenses | 5.75M | 12.85M | 2.70M | 720.64K | 166.54K |
Operating income | -5.93M | -5.38M | -2.71M | -720.64K | -166.54K |
Other income (expenses), net | -1.59M | -12.73M | -2.08M | -339.14K | -24.78K |
Income before tax | -7.52M | -18.11M | -4.79M | -1.05M | -191.32K |
Income tax expense | -261K | -707K | -13K | 339.15K | -47.45K |
Net income | -7.14M | -17.41M | -4.78M | -1.39M | -191.32K |
Earnings per share | |||||
Basic EPS | -0.12 | -0.3 | -0.64 | -0.23 | -0.03 |
Diluted EPS | -0.12 | -0.3 | -0.64 | -0.23 | -0.03 |
| Data source | Data source | Data source | Data source | Data source |